Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Short Interest Down 6.8% in October

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 3,730,000 shares, a decrease of 6.8% from the September 30th total of 4,000,000 shares. Approximately 12.1% of the company’s shares are short […]

Related Keywords

Switzerland ,Canada ,Swiss , ,Life Insurance Co ,Ameritas Investment Partners Inc ,Group Plc ,Swiss National Bank ,Credit Suisse Group ,Jpmorgan Chase Co ,Royal Bank ,Monte Rosa Therapeutics Inc ,Nasdaq ,Monte Rosa Therapeutics ,Get Free Report ,Rosa Therapeutics ,Investment Partners ,National Bank ,General Group Plc ,Suisse Group ,Monte Rosa Therapeutics Daily ,Nasdaq Glue ,Glue ,Medical ,Stocks ,Options ,Put ,Call ,